NEUROPHET Inc.

About NEUROPHET Inc.

NEUROPHET Inc. operates in the Software & AI space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Nuclear Medicine Today · 2026-03-10
  Neurophet Inc files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-12-17
  Neurophet Inc partners with academic center on Actinium-225 program
  The work builds on more than a decade of radiochemistry collaboration.
• Imaging Wire · 2026-05-08
  Neurophet Inc closes Series C round to scale radiopharma manufacturing
  Coverage notes the company's growing footprint in the radioligand therapy space.
• STAT News · 2026-06-27
  Neurophet Inc publishes dosimetry data at SNMMI 2026
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.